Clinical Trials in Tennessee

Showing 9741-9760 of 20,239 trials

CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19

NCT04575038

This study will assess the efficacy and safety of DHODHi (brequinar) as an antiviral via 5 days of treatment of participants with positive COVID-19 and at least one symptom of COVI019 in an out-patient setting. The study is multi-center, randomized, and placebo-controlled.

COVID-19 Infection

Clear Creek Bio, Inc.115 participantsStarted Nov 2020

Homewood, Alabama, United States • Long Beach, California, United States • Doral, Florida, United States +11 more locations

TERMINATEDPhase 1/229 miles

Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease

NCT03225846

PRECISION-HD2 is a Phase 1b/2a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single and multiple doses of WVE-120102 in adult patients with early manifest Huntington's disease (HD) who carry a targeted single nucleotide polymorphism (SNP) rs362331 (SNP2).

Huntington's Disease

Wave Life Sciences Ltd.88 participantsStarted Jul 2017

La Jolla, California, United States • Sacramento, California, United States • Boston, Massachusetts, United States +23 more locations

CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19

Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease

Find Trials by Condition in Tennessee

Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)

The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease

BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)

A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)

LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis

Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis

Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma

Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis

Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer

A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)

Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer

The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery

Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome

ET-01 in Subjects With Lateral Canthal Lines, LCL-207

A Study of RG-012 in Subjects With Alport Syndrome

Immunogenicity and Safety of a Purified Vero Rabies Vaccine